JACQUELINE RAFFAELE: Open Payments
NPI 1184347395 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 43 payments from 12 companies in 2025. Trend: 2023 $971 · 2024 $2,169 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $350 |
| Axsome Therapeutics, Inc. | 8 | $218 |
| Supernus Pharmaceuticals, Inc. | 5 | $174 |
| Neurocrine BioSciences, Inc. | 2 | $150 |
| Alkermes, Inc. | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: VRAYLAR, Auvelity, Qelbree, INGREZZA, CAPLYTA, REXULTI, ARISTADA, AUSTEDO XR.
Industry payments across SC — which companies pay providers there.
